RIL
ALDX icon

Rothschild Investment LLC’s Aldeyra Therapeutics ALDX Stock Holding History

Rothschild Investment LLC’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$756 Sell
355
-5
-1% -$9 ﹤0.01% 3156
2026
Q1 		$608 Buy
360
+235
+188% +$1.03K ﹤0.01% 3057
2025
Q4 		$648 Sell
125
-10
-7% -$51 ﹤0.01% 2844
2025
Q3 		$705 Buy
135
+50
+59% +$261 ﹤0.01% 2723
2025
Q2 		$326 Buy
+85
New +$220 ﹤0.01% 2846

Other funds holding ALDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Rothschild Investment LLC's ALDX Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Aldeyra Therapeutics (ALDX) stake by 1.4% in Q2 2026, selling an estimated $9 and leaving 355 shares worth $756. The position accounts for ﹤0.01% of the portfolio, ranked #3156.

Rothschild Investment LLC first reported a position in ALDX in Q2 2025 and has held it in 5 quarters since. 33 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Rothschild Investment LLC held 355 shares of Aldeyra Therapeutics worth $756 as of Q2 2026.
  • Rothschild Investment LLC sold 5 Aldeyra Therapeutics shares in Q2 2026, an estimated $9.
  • Aldeyra Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3156 holding.
  • Rothschild Investment LLC first reported a position in Aldeyra Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 33 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.